Wei Cai Selected Research

Parenteral Nutrition

11/2022	Lactobacillus plantarum supplementation alleviates liver and intestinal injury in parenteral nutrition-fed piglets.
1/2022	Intestinal Continuity Alleviates Pediatric Intestinal Failure-Associated Liver Disease.
1/2022	Fish oil-based lipid emulsion alleviates parenteral nutrition-associated liver diseases and intestinal injury in piglets.
1/2022	Role of the Gut Microbiota in Parenteral Nutrition-Associated Liver Disease: From Current Knowledge to Future Opportunities.
4/2021	Alterations of gut microbiota and serum bile acids are associated with parenteral nutrition-associated liver disease.
1/2021	Variants in the Enteric Smooth Muscle Actin γ-2 Cause Pediatric Intestinal Pseudo-obstruction in Chinese Patients.
1/2021	The Farnesoid X Receptor Agonist Tropifexor Prevents Liver Damage in Parenteral Nutrition-fed Neonatal Piglets.
11/2020	Risk factors of parenteral nutrition-associated cholestasis in very-low-birthweight infants.
1/2020	Impact of Postnatal Antibiotics and Parenteral Nutrition on the Gut Microbiota in Preterm Infants During Early Life.
1/2020	Lipid Emulsion Use in Pediatric Patients Requiring Long-Term Parenteral Nutrition.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei Cai Research Topics

Disease

73	Neoplasms (Cancer) 10/2022 - 01/2002
36	Inflammation (Inflammations) 04/2022 - 01/2012
32	Liver Diseases (Liver Disease) 11/2022 - 10/2006
23	Infections 01/2022 - 04/2009
20	Fibrosis (Cirrhosis) 05/2022 - 06/2009
20	Body Weight (Weight, Body) 01/2022 - 11/2008
15	Insulin Resistance 01/2022 - 08/2012
15	Chronic Hepatitis B 01/2022 - 12/2007
14	Intestinal Failure 09/2022 - 12/2016
14	Stroke (Strokes) 04/2021 - 09/2015
12	Biliary Atresia 01/2022 - 01/2012
12	Cholestasis 01/2022 - 10/2006
11	Ischemic Stroke 01/2022 - 09/2016
11	Obesity 11/2021 - 07/2007
9	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2010
9	Short Bowel Syndrome 01/2022 - 07/2007
8	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2002
8	Carcinogenesis 01/2022 - 01/2013
8	Sepsis (Septicemia) 01/2022 - 07/2014
8	Ischemia 07/2021 - 09/2015
8	Liver Cirrhosis (Hepatic Cirrhosis) 09/2020 - 01/2013
7	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 02/2015
7	Hypertension (High Blood Pressure) 05/2022 - 09/2017
7	Autoimmune Diseases (Autoimmune Disease) 03/2022 - 03/2016
7	Poliomyelitis (Polio) 01/2021 - 12/2016
7	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2011
7	Carcinoma (Carcinomatosis) 01/2017 - 01/2002
6	Atherosclerosis 01/2022 - 08/2006
6	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 09/2005
6	Hypoxia (Hypoxemia) 01/2021 - 08/2012
5	Hemorrhage 04/2022 - 05/2006
5	Pancreatitis 01/2022 - 01/2007
5	Wounds and Injuries (Trauma) 01/2022 - 11/2016
5	Asthma (Bronchial Asthma) 06/2021 - 01/2017
5	Brain Injuries (Brain Injury) 03/2021 - 01/2017
5	Osteosarcoma (Osteogenic Sarcoma) 03/2021 - 11/2017
5	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2015
5	Colitis 01/2019 - 01/2016
4	Liver Failure 01/2022 - 05/2016
4	Necrotizing Enterocolitis 01/2022 - 08/2013
4	Leukemia 12/2021 - 09/2010
4	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2021 - 07/2015
4	Pain (Aches) 07/2021 - 12/2005
4	Atrophy 01/2021 - 10/2010
4	Adenocarcinoma 01/2021 - 01/2002

Drug/Important Bio-Agent (IBA)

32	Proteins (Proteins, Gene)FDA Link 10/2022 - 08/2006
17	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2010
17	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2008
17	CytokinesIBA 01/2021 - 09/2014
15	Bile Acids and Salts (Bile Acids)IBA 04/2021 - 01/2012
14	LipidsIBA 01/2022 - 01/2013
12	Messenger RNA (mRNA)IBA 03/2022 - 05/2010
11	VaccinesIBA 05/2022 - 01/2015
11	Pharmaceutical PreparationsIBA 03/2022 - 06/2013
11	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2009
8	Insulin (Novolin)FDA Link 01/2022 - 01/2013
8	Biological ProductsIBA 11/2021 - 01/2002
8	InflammasomesIBA 03/2021 - 11/2015
7	BilirubinIBA 05/2022 - 11/2007
7	EmulsionsIBA 01/2022 - 01/2016
7	EnzymesIBA 01/2022 - 02/2015
7	Interleukin-6 (Interleukin 6)IBA 01/2021 - 03/2011
7	Antiviral Agents (Antivirals)IBA 01/2021 - 04/2009
6	RNA (Ribonucleic Acid)IBA 09/2022 - 03/2015
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020 - 01/2015
6	LigandsIBA 04/2018 - 07/2014
6	Triglycerides (Triacylglycerol)IBA 01/2018 - 01/2013
5	Indicators and Reagents (Reagents)IBA 05/2022 - 01/2015
5	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 06/2009
5	FlavonoidsIBA 01/2022 - 07/2016
5	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021 - 01/2018
5	AcidsIBA 01/2021 - 12/2005
5	Neuroprotective AgentsIBA 01/2021 - 08/2015
5	AntioxidantsIBA 01/2021 - 07/2007
5	C-Reactive ProteinIBA 01/2016 - 11/2013
4	Cadherins (E-Cadherin)IBA 10/2022 - 05/2014
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 08/2015
4	Fish OilsIBA 01/2022 - 10/2018
4	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021 - 01/2007
4	Immunoglobulins (Immunoglobulin)IBA 08/2021 - 12/2014
4	Therapeutic UsesIBA 03/2021 - 01/2007
4	Immunoglobulin G (IgG)IBA 01/2021 - 01/2013
4	Alanine Transaminase (SGPT)IBA 01/2021 - 12/2007
4	InterleukinsIBA 01/2021 - 11/2013
4	AntigensIBA 01/2021 - 03/2015
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 05/2017
4	Interleukin-9 (Interleukin 9)IBA 01/2021 - 07/2017
4	AlbuminsIBA 01/2021 - 11/2013
4	Anti-Bacterial Agents (Antibiotics)IBA 12/2020 - 01/2018

Therapy/Procedure

39	Therapeutics 05/2022 - 07/2005
26	Parenteral Nutrition 11/2022 - 08/2007
8	Drug Therapy (Chemotherapy) 05/2022 - 09/2005
7	Total Parenteral Nutrition 09/2022 - 10/2006
7	Length of Stay 01/2022 - 09/2009
6	Catheters 01/2022 - 01/2018
5	Stents 04/2022 - 04/2015
5	Ligation 01/2021 - 04/2015
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2022 - 03/2011
4	Enteral Nutrition (Feeding, Tube) 01/2022 - 10/2009
4	Immunotherapy 01/2021 - 01/2015